{"public_id":"cl_8a8f703f9df9ed6272c9604895080dcc","status":"active","superseded_by_public_id":null,"corpus_id":13697518,"text":"The first-year cumulative incidence of angiotensin-converting enzyme inhibitor-associated angioedema varies between 0.12 and 0.30 per 100 patient-years.","confidence":0.97,"paper":{"corpus_id":13697518,"title":"Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies","url":"https://sah.borca.ai/papers/13697518"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.97,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_7ab47c1a87701efe8a82d411620eafb5","name":"angiotensin-converting enzyme inhibitor-associated angioedema","description":"Angioedema associated with treatment using angiotensin-converting enzyme inhibitors.","types":["condition"],"url":"https://sah.borca.ai/concepts/co_7ab47c1a87701efe8a82d411620eafb5"},{"public_id":"co_8d515ab34e5794327c301eb5bb947977","name":"100 patient-years","description":"A rate denominator expressing events per one hundred patient-years of observation.","types":["unit"],"url":"https://sah.borca.ai/concepts/co_8d515ab34e5794327c301eb5bb947977"},{"public_id":"co_cb71314bd1d6a6d81aff9fd0da7902ee","name":"first-year cumulative incidence","description":"The accumulated occurrence of new cases during the first year of follow-up.","types":["epidemiological measure"],"url":"https://sah.borca.ai/concepts/co_cb71314bd1d6a6d81aff9fd0da7902ee"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_8a8f703f9df9ed6272c9604895080dcc"}